Advertisement
Screener

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

KRAIG BIOCRAFT LABORATORIES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

KRAIG BIOCRAFT LABORATORIES, INC. (KBLB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 2.50 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-13

  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 2.50M shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-09-30 was 8.50M shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-06-30 was 0.00 shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 461.00K shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 2.50M shares.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 3.60M shares, a 77.14% decline from fiscal 2017.
  • KRAIG BIOCRAFT LABORATORIES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 15.75M shares, a 61.86% decline from fiscal 2016.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2026-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
2.50M shares
10-Q · filed 2026-08-13
2026-03-312.50M shares
10-Q · filed 2026-05-14
2025-12-318.00M shares
POS AM · filed 2026-05-11
2024-12-31461.00K shares
10-K · filed 2025-03-28
2021-12-312.50M shares
10-K · filed 2023-03-29
2021-07-08500.00K shares
10-Q · filed 2021-11-05
2021-01-252.50M shares
10-Q · filed 2023-08-14
2019-09-308.50M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
8.50M shares
derived: sum of 2 quarters · filed 2019-11-13
30.70M shares
10-Q · filed 2019-11-13
30.70M shares
derived: sum of 4 quarters · filed 2019-11-13
2019-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12
22.20M shares
10-Q · filed 2019-08-12
22.20M shares
derived: sum of 3 quarters · filed 2019-08-12
22.20M shares
derived: sum of 4 quarters · filed 2019-08-12
2019-03-3122.20M shares
10-Q · filed 2019-05-13
22.20M shares
derived: sum of 2 quarters · filed 2019-05-13
22.20M shares
derived: sum of 3 quarters · filed 2019-05-13
22.20M shares
derived: sum of 4 quarters · filed 2019-05-13
2018-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
0.00 shares
derived: sum of 2 quarters · filed 2019-03-29
0.00 shares
derived: sum of 3 quarters · filed 2019-03-29
3.60M shares
10-K · filed 2019-03-29
2018-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
0.00 shares
derived: sum of 2 quarters · filed 2018-11-13
3.60M shares
10-Q · filed 2018-11-13
3.60M shares
derived: sum of 4 quarters · filed 2018-11-13
2018-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10
3.60M shares
10-Q · filed 2018-08-10
3.60M shares
derived: sum of 3 quarters · filed 2018-08-10
3.60M shares
derived: sum of 4 quarters · filed 2018-08-10
2018-03-313.60M shares
10-Q · filed 2018-05-11
3.60M shares
derived: sum of 2 quarters · filed 2018-05-11
3.60M shares
derived: sum of 3 quarters · filed 2018-05-11
2017-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23
0.00 shares
derived: sum of 2 quarters · filed 2018-03-23
15.75M shares
10-K · filed 2018-03-23
2017-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-15
15.75M shares
10-Q · filed 2017-11-15
2017-06-3015.75M shares
10-Q · filed 2017-08-14
2016-12-3117.30M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
35.30M shares
derived: sum of 2 quarters · filed 2017-03-22
35.30M shares
derived: sum of 3 quarters · filed 2017-03-22
41.30M shares
10-K · filed 2017-03-22
2016-09-3018.00M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
18.00M shares
derived: sum of 2 quarters · filed 2016-11-14
24.00M shares
10-Q · filed 2016-11-14
24.00M shares
derived: sum of 4 quarters · filed 2017-03-22
2016-06-300.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12
6.00M shares
10-Q · filed 2016-08-12
6.00M shares
derived: sum of 3 quarters · filed 2017-03-22
6.00M shares
derived: sum of 4 quarters · filed 2017-03-22
2016-03-316.00M shares
10-Q · filed 2016-05-13
6.00M shares
derived: sum of 2 quarters · filed 2017-03-22
6.00M shares
derived: sum of 3 quarters · filed 2017-03-22
2015-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22
0.00 shares
derived: sum of 2 quarters · filed 2017-03-22
20.00M shares
10-K · filed 2017-03-22
2015-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
20.00M shares
10-Q · filed 2015-11-05
2015-06-3020.00M shares
10-Q · filed 2015-08-11
2014-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
0.00 shares
derived: sum of 2 quarters · filed 2016-03-30
3.00M shares
derived: sum of 3 quarters · filed 2016-03-30
10.20M shares
10-K · filed 2016-03-30
2014-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23
3.00M shares
derived: sum of 2 quarters · filed 2014-10-23
10.20M shares
10-Q · filed 2014-10-23
10.20M shares
derived: sum of 4 quarters · filed 2015-03-31
2014-06-303.00M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14
10.20M shares
10-Q · filed 2014-08-14
10.20M shares
derived: sum of 3 quarters · filed 2015-03-31
2014-03-317.20M shares
10-Q · filed 2014-05-15
7.20M shares
derived: sum of 2 quarters · filed 2015-03-31
2013-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
10.00M shares
10-K · filed 2015-03-31
18.00M shares
10-K · filed 2014-04-15
2013-09-3010.00M shares
10-Q · filed 2013-11-19
2012-12-3110.00M shares
10-Q · filed 2014-10-23